XLONVLG
Market cap59mUSD
Dec 27, Last price
37.50GBP
1D
0.00%
1Q
-21.88%
IPO
-63.36%
Name
Venture Life Group PLC
Chart & Performance
Profile
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 51,410 16.89% | 43,980 34.24% | 32,762 8.93% | |||||||
Cost of revenue | 31,563 | 26,521 | 20,120 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 19,847 | 17,459 | 12,642 | |||||||
NOPBT Margin | 38.61% | 39.70% | 38.59% | |||||||
Operating Taxes | 202 | 186 | (1,456) | |||||||
Tax Rate | 1.02% | 1.07% | ||||||||
NOPAT | 19,645 | 17,273 | 14,098 | |||||||
Net income | 921 77.12% | 520 -78.35% | 2,402 1.44% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 224 | |||||||||
BB yield | -0.46% | |||||||||
Debt | ||||||||||
Debt current | 20,342 | 3,867 | 620 | |||||||
Long-term debt | 9,144 | 30,497 | 16,355 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 1,544 | 1,461 | 1,236 | |||||||
Net debt | 23,864 | 33,515 | 16,026 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 8,220 | 5,566 | 601 | |||||||
CAPEX | (820) | (4,206) | (3,262) | |||||||
Cash from investing activities | (5,340) | (11,688) | (39,179) | |||||||
Cash from financing activities | (2,806) | 6,922 | 1,502 | |||||||
FCF | 19,491 | 12,387 | 7,489 | |||||||
Balance | ||||||||||
Cash | 5,622 | 5,631 | 5,235 | |||||||
Long term investments | (4,782) | (4,286) | ||||||||
Excess cash | 3,052 | |||||||||
Stockholders' equity | 10,294 | 2,043 | (230) | |||||||
Invested Capital | 99,138 | 103,075 | 87,171 | |||||||
ROIC | 19.43% | 18.16% | 16.34% | |||||||
ROCE | 18.02% | 15.62% | 13.52% | |||||||
EV | ||||||||||
Common stock shares outstanding | 133,635 | 133,394 | 133,819 | |||||||
Price | 0.34 -8.22% | 0.37 21.67% | 0.30 -67.74% | |||||||
Market cap | 44,768 -8.05% | 48,689 21.28% | 40,146 -53.79% | |||||||
EV | 68,632 | 82,204 | 56,172 | |||||||
EBITDA | 26,491 | 22,844 | 16,344 | |||||||
EV/EBITDA | 2.59 | 3.60 | 3.44 | |||||||
Interest | 2,181 | 1,522 | 514 | |||||||
Interest/NOPBT | 10.99% | 8.72% | 4.07% |